Literature DB >> 25452440

High-dose chemotherapy for recurrent ovarian germ cell tumors.

Natraj Reddy Ammakkanavar1, Daniela Matei1, Rafat Abonour1, Lawrence H Einhorn2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25452440     DOI: 10.1200/JCO.2014.59.4325

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  8 in total

1.  Comparable outcomes following two or three cycles of high-dose chemotherapy and autologous stem cell transplantation for patients with relapsed/refractory germ cell tumors.

Authors:  Z DeFilipp; C B Rosand; D A Goldstein; V A Master; B C Carthon; W B Harris; O Kucuk; Z Al-Kadhimi; J B Cohen; C R Flowers; M J Lechowicz; A K Nooka; J L Kaufman; A A Langston; Z Chen; J Arora; E K Waller
Journal:  Bone Marrow Transplant       Date:  2016-07-18       Impact factor: 5.483

2.  Development of a risk stratification system to guide treatment for female germ cell tumors.

Authors:  Jane L Meisel; Kaitlin M Woo; Nora Sudarsan; Jana Eng; Sujata Patil; Erin P Jacobsen; Rajmohan Murali; Ginger J Gardner; George J Bosl; Carol Aghajanian; Darren R Feldman
Journal:  Gynecol Oncol       Date:  2015-06-24       Impact factor: 5.482

3.  Vulvar yolk sac tumor diagnosed during pregnancy, with recurrence during subsequent second pregnancy.

Authors:  Wen Xu; Ashley Moon; Naven Chetty; Rohan Lourie; Catherine Shannon
Journal:  Gynecol Oncol Rep       Date:  2015-03-28

Review 4.  Systemic anti-cancer treatment in malignant ovarian germ cell tumours (MOGCTs): current management and promising approaches.

Authors:  Mario Uccello; Stergios Boussios; Eleftherios P Samartzis; Michele Moschetta
Journal:  Ann Transl Med       Date:  2020-12

5.  High-dose chemotherapy and stem-cell rescue for salvage therapy for relapsed malignant mixed ovarian germ cell tumor: A case report.

Authors:  Sarah Sears; Sareena Singh; Hadi Shojaei; Raymond Redline; Kimberly Resnick
Journal:  Gynecol Oncol Rep       Date:  2017-09-29

Review 6.  Molecular Pathways and Targeted Therapies for Malignant Ovarian Germ Cell Tumors and Sex Cord-Stromal Tumors: A Contemporary Review.

Authors:  Asaf Maoz; Koji Matsuo; Marcia A Ciccone; Shinya Matsuzaki; Maximilian Klar; Lynda D Roman; Anil K Sood; David M Gershenson
Journal:  Cancers (Basel)       Date:  2020-05-29       Impact factor: 6.639

7.  Malignant mixed ovarian germ cell tumor composed of immature teratoma, yolk sac tumor and embryonal carcinoma harboring an EGFR mutation: a case report.

Authors:  Yao Wang; Jia-Xin Yang; Mei Yu; Dong-Yan Cao; Keng Shen
Journal:  Onco Targets Ther       Date:  2018-10-12       Impact factor: 4.147

Review 8.  Therapeutic Challenges for Cisplatin-Resistant Ovarian Germ Cell Tumors.

Authors:  Ugo De Giorgi; Chiara Casadei; Alice Bergamini; Laura Attademo; Gennaro Cormio; Domenica Lorusso; Sandro Pignata; Giorgia Mangili
Journal:  Cancers (Basel)       Date:  2019-10-17       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.